Editorial: In touch with psoriasis: A patient-centred approach to therapy

Journal of the European Academy of Dermatology and Venereology

Volumn 25, Issue SUPPL. 4, 2011, Pages 1-2

  Langley, R ^a   Reich, K ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b DERMATOLOGIKUM HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE DIPROPIONATE PLUS CALCIPOTRIOL; DERMATOLOGICAL AGENT;

BODY SURFACE; CLINICAL FEATURE; DISEASE SEVERITY; EDITORIAL; HUMAN; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SYMPTOM; DRUG COMBINATION; PATIENT CARE;

DERMATOLOGIC AGENTS; DRUG COMBINATIONS; HUMANS; PATIENT-CENTERED CARE; PRACTICE GUIDELINES AS TOPIC; PSORIASIS;

EID: 79955386742     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2011.04058.x     Document Type: Editorial

References (16)

1. Finlay AY, Coles EC,. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132: 236-244.
2. Bhosle MJ, Kulkarni A, Feldman SR, Balkrishnan R,. Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006; 4: 35.
3. Langley RG, Krueger GG, Griffiths CE,. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (Suppl. 2): ii18-ii23. Discussion ii24-25. (Pubitemid 40288514)
4. Green AC,. Australian Aborigines and psoriasis. Australas J Dermatol 1984; 25: 18-24. (Pubitemid 14071599)
5. Henseler T, Christophers E,. Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456. (Pubitemid 15016489)
6. Smith AE, Kassab JY, Rowland Payne CM, Beer WE,. Bimodality in age of onset of psoriasis, in both patients and their relatives. Dermatology 1993; 186: 181-186. (Pubitemid 23096516)
7. Langley RG, Ellis CN,. Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment. J Am Acad Dermatol 2004; 51: 563-569. (Pubitemid 39278075)
8. Naldi L,. Scoring and monitoring the severity of psoriasis. What is the preferred method? What is the ideal method? Is PASI passé? Facts and controversies. Clin Dermatol 2010; 28: 67-72.
9. Augustin M, Reich K, Reich C, et al. Quality of psoriasis care in Germany-results of the national study PsoHealth 2007. J Dtsch Dermatol Ges 2008; 6: 640-645.
10. Stern RS, Nijsten T, Feldman SR, Margolis DJ, Rolstad T,. Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004; 9: 136-139. (Pubitemid 38457271)
11. Finlay AY,. Current severe psoriasis and the rule of tens. Br J Dermatol 2005; 152: 861-867. (Pubitemid 40704922)
12. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-216. (Pubitemid 24194579)
13. Gupta MA, Schork NJ, Gupta AK, Kirkby S, Ellis CN,. Suicidal ideation in psoriasis. Int J Dermatol 1993; 32: 188-190. (Pubitemid 23098574)
14. Heydendael VM, de Borgie CA, Spuls PI, Bossuyt PM, Bos JD, de Rie MA,. The burden of psoriasis is not determined by disease severity only. J Investig Dermatol Symp Proc 2004; 9: 131-135. (Pubitemid 38457270)
15. Schön MP, Boehncke WH,. Psoriasis. N Engl J Med 2005; 352: 1899-1912. (Pubitemid 40627816)
16. Pariser DM, Bagel J, Gelfand JM, et al. National Psoriasis Foundation. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol 2007; 143: 239-242. (Pubitemid 46294591)